Table of Contents

company-logo

Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits designed for specific workflow, such as template preparation kit to convert DNA into SMRTbell double-stranded DNA library formats, including molecular biology reagents, such as ligase, buffers, and exonucleases. It also offers binding kits, such as modified DNA polymerase used to bind SMRTbell libraries to the polymerase in preparation for sequencing; and sequencing kits comprise reagents required for on-instrument, real-time sequencing, including the phospholinked nucleotides. The company serves research institutions; commercial laboratories; genome centers; public health labs, hospitals and clinical research institutes, contract research organizations, and academic institutions; pharmaceutical companies; and agricultural companies. It markets its products through a direct sales force in North America and Europe, as well as through distribution partners in Asia, Europe, the Middle East, Africa, and Latin America. Pacific Biosciences of California, Inc. has a development and commercialization agreement with Invitae Corporation. The company was formerly known as Nanofluidics, Inc. and changed its name to Pacific Biosciences of California, Inc. in 2005. Pacific Biosciences of California, Inc. was incorporated in 2000 and is headquartered in Menlo Park, California.

Pacific Biosciences of California Dividend Announcement

• Pacific Biosciences of California does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on Pacific Biosciences of California dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Pacific Biosciences of California Dividend History

Pacific Biosciences of California Dividend Yield

Pacific Biosciences of California current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Pacific Biosciences of California stock? Use our calculator to estimate your expected dividend yield:

Pacific Biosciences of California Financial Ratios

P/E ratio-1.71
PEG ratio0.04
P/B ratio1.39
ROE-61.44%
Payout ratio0.00%
Current ratio8.01
Quick ratio7.14
Cash Ratio1.27

Pacific Biosciences of California Dividend FAQ

Does Pacific Biosciences of California stock pay dividends?
Pacific Biosciences of California does not currently pay dividends to its shareholders.
Has Pacific Biosciences of California ever paid a dividend?
No, Pacific Biosciences of California has no a history of paying dividends to its shareholders. Pacific Biosciences of California is not known for its dividend payments.
Why doesn't Pacific Biosciences of California pay dividends?
There are several potential reasons why Pacific Biosciences of California would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Pacific Biosciences of California ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Pacific Biosciences of California has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Pacific Biosciences of California a dividend aristocrat?
Pacific Biosciences of California is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Pacific Biosciences of California a dividend king?
Pacific Biosciences of California is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Pacific Biosciences of California a dividend stock?
No, Pacific Biosciences of California is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Pacific Biosciences of California stocks?
To buy Pacific Biosciences of California you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Pacific Biosciences of California stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.